Activity
Mon
Wed
Fri
Sun
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
What is this?
Less
More

Owned by John

The Peptide Daily Brief

545 members • Free

Independent peptide research, education, and discussion. Built with Stack Tracker and supported by n1 Aminos for verified research supply.

Memberships

Longevity and Biohacking Labs

220 members • Free

Biohacking Elite

278 members • Free

Hub Biohackers

126 members • Free

Peptide Association Community

954 members • Free

Longevity Lab

711 members • Free

Tony Huge Evolution

3.7k members • Free

Precision Health w PA Courtney

158 members • Free

Biohackers Buyers Club

136 members • Free

Good Looks Plus Shenanigans

750 members • $20

14 contributions to Tony Huge Evolution
🚨 BREAKING: The “Too Dangerous” Molecule Is About to Become a Miracle 🚨
They said it was risky. They said it was illegal. They said it was counterfeit, contaminated, reckless, life-threatening. Now? They’re preparing to patent it, brand it, and call it revolutionary. 🧬 The Data They’re Celebrating Eli Lilly’s Phase 3 TRIUMPH-4 data on retatrutide shows: 📉 28.7% average body-weight reduction at 68 weeks (12 mg dose) 🦵 Significant reduction in knee pain (WOMAC improvements) ❤️ Improvements in triglycerides, non-HDL cholesterol, hs-CRP, and systolic BP 🔥 ~23–24% of participants lost ≥35% body weight (bariatric-range outcomes) That’s not incremental. That’s surgical territory. And yes, tolerability issues were there: Nausea ~38–43% Diarrhea ~33–35% Vomiting ~20% Discontinuation rates up to ~18% New signal: dysesthesia Some participants reportedly stopped because they lost too much weight. Let that sink in. ⚖️ Now Remember the Messaging From Not Long Ago… Before commercial approval was realistic, the narrative was very different. The tone was: “Unapproved GLP-1 products are dangerous.” “Compounded versions cause hospitalizations.” “Research-use ingredients are illegal and harmful.” “Online sales = counterfeit, contamination, overdoses.” Regulators and corporate PR leaned heavily into: Counterfeit scare language Hospitalization statistics Cease-and-desist campaigns Litigation against telehealth and compounders Anything outside the branded channel? Framed as reckless. Even retatrutide as an API was explicitly warned against in FDA communications. The emotional positioning was clear: If it’s not ours, it’s unsafe. 🔄 And Now? Now the same molecule is being positioned as: Historic Breakthrough Bariatric-level Cardiometabolically transformative Soon it will likely be: Patented Exclusively distributed Marketed as the future of obesity treatment “Well tolerated and effective when used appropriately” Same compound. Different control. 🧠 The Pattern This isn’t about denying safety concerns. Large-scale human data matters.
0
0
🚨 BREAKING: The “Too Dangerous” Molecule Is About to Become a Miracle 🚨
🚀 Stack Tracker 2.0 Is Coming
This isn’t an update. Share this post and update with your greater peptide communities to help us spread the word!!!! It’s a rebuild. Stack Tracker is moving onto its own dedicated servers — fully rebuilt from the ground up, fully HIPAA compliant, and engineered by a world-class development team. New architecture. New design language. New UI/UX. Massively improved reliability. Way faster performance. And functionality that finally matches the long-term vision. This is the version we always intended to launch. 🧬 Bigger Than Tracking Stack Tracker 2.0 isn’t just a tracking tool anymore. It’s infrastructure. For years, optimization conversations have lived on platforms that throttle content, shadow ban discussions, censor nuance, and disconnect providers from serious clients. That era is ending. The rebuild introduces the ability to connect directly with providers and coaches who actually understand this space — inside a structured, data-driven environment. Your full protocol visible. Compliance tracked. Wearable data integrated. Real conversations happening without algorithm interference. Optimization with freedom. Not censorship. And yes — we already have several key providers lined up who are ready to join the cause. 🎤 Official Debut We’re unveiling the full rebuild LIVE at Biohacker World Conference, March 28–29. [https://www.biohackers.world/](https://www.biohackers.world/) If you’ve never been, it’s one of the highest-signal gatherings in the biohacking space. Founders. Researchers. Builders. Real operators. We’re not just attending. We’re launching. 🎟 Who’s In? Last time, we were able to secure a couple of free tickets for the community. If we can make that happen again… Who would actually go? Find this post on The Peptide Daily Brief and drop an, “I’m in,” your city, and why you should get the ticket. Stack Tracker 2.0 isn’t just better software.
🚀 Stack Tracker 2.0 Is Coming
0 likes • 8d
FYI You can still join the beta launch now at StackTracker.info and lock in lifetime pricing and early access on 03/02/2026 to help us test and work out any bugs in the system... We would love that 🥰
🧬 The Peptide “Stacking” Mistake Almost Everyone Makes
Most people don’t fail because their stack is weak. They fail because they stack without structure. Here’s how it usually goes: Week 1: Start BPC-157. Week 2: Add TB-500 because someone said “synergy.” Week 3: Add GHK-Cu for skin and collagen. Week 4: Add CJC/Ipamorelin for recovery. Week 6: Energy feels off. Sleep is weird. Not sure what’s working. Now what? You’ve created signal noise. --- 🧠 The Real Problem: No Isolation Phase In research environments, you isolate variables. In biohacking culture, people isolate nothing. When you introduce multiple peptides within 30 days, you lose the ability to identify: * What’s driving progress * What’s causing side effects * What needs to be adjusted More compounds ≠ more results. It often just means more confusion. --- 🧪 The 3-Phase Structure That Actually Works Phase 1 — Baseline (2 weeks) Keep sleep, hydration, calories, and training stable. No new compounds. Phase 2 — Core Compound (4–6 weeks) Introduce ONE primary goal compound. Track sleep, energy, inflammation, and performance. Phase 3 — Strategic Add-On Only layer something in if: * The main goal isn’t fully met * Side effects are minimal * You can clearly explain what mechanism you’re targeting If you can’t articulate what a peptide is supposed to change… don’t add it. 🔬 Build Around the Goal — Not the Hype • Tendon issue → Repair-first bias • Chronic inflammation → Inflammation-first bias • Body comp plateau → Metabolic-first bias • Cosmetic focus → ECM-first bias Stacks should be intentional. Not impulsive. If you want deeper breakdowns like this — structured, mechanism-first, no hype — that’s exactly what we do inside The Peptide Daily Brief. Drop your current stack + goal below, and we’ll break down whether it’s structured… or chaotic.
1
0
Im thinking about stacking Ss-31, tesa/ipamorelin, igf-lr3 and cjc-1295
Can Anyone help with how much how often and are all these good together? The tesamorelin/Impamorelin is 12 mg and 2 MG blend Igf3-lr3 is a 1mg Cjc-1295 with dac is 5mg. I am very new to the peptide use . I have already run a healing cycle . With Ret, Mot-c, bpc-157, I am feeling amazing. My weight has stayed the same but my waist and other areas have change alot. Mostly carnivore diet with a few carbs which for me helps with the reta response. Working out at lest 4 times a week So what do you guys think?
0 likes • 25d
The fact that your waist and body composition are changing without scale loss tells us your metabolism and nutrient partitioning are doing what they should. That’s a good sign, not something to bulldoze past. A few high-level thoughts before getting into “how much / how often”: • Yes, these can work together, but stacking all of them at once when you’re newer isn’t always the best move • You’re already training 4x/week and eating mostly carnivore — that’s a strong foundation • More peptides ≠ better results if recovery or signaling gets noisy Now, let’s break this down conceptually. Tesamorelin + Ipamorelin + CJC (DAC). This is essentially a growth hormone signaling stack. Running all three is powerful, but also redundant if timing isn’t clean. For newer users, people often do better starting with either: - Tesa/Ipa togetheror - CJC (DAC) alone Then layering later if needed. CJC with DAC is long-acting, so it changes how often you’d dose everything else. IGF-1 LR3. This is where I’d urge the most caution. IGF is potent, very anabolic, and timing matters a lot. It’s usually best introduced after you know how you respond to GH-side signaling, not at the same time as multiple new compounds. SS-31Different lane entirely. More mitochondrial efficiency and fatigue resistance. This one pairs nicely with training, but again, it's better evaluated when added alone so you know what’s actually helping. A couple of important questions before anyone gives you clean numbers: - Are you training fasted or fed? - Any drop in energy or recovery since adding Reta? - Morning vs evening workouts? - Primary goal right now: recomposition, endurance, recovery, or size? One more thing worth saying plainly: Reta can lower overall calories and training drive for some people. If strength or intensity starts dipping, stacking aggressive anabolic signals on top can work against your results. If this were me, I’d: 1. Keep what’s working 2. Add one new lever at a time 3. Let body comp and training performance guide the next addition
0 likes • 25d
@Norman Miles no doubt. Those who train hard know the need. lol
1 like • 25d
Short answer: they’re usually not run “year-round” in the traditional sense, even though many people cycle them repeatedly over time. BPC-157 and TB-500 work best when there’s a reason — injury, inflammation, connective tissue stress, recovery from heavy training, etc. Most people see the strongest benefit when they’re run in defined blocks, then paused. Common ways people approach this: - Run them during an acute injury or flare-up - Use a 4–8 week cycle during heavy training phases - Take a break once pain, mobility, or inflammation stabilizes - Reintroduce later if needed Using them continuously without a signal to fix doesn’t usually add extra benefit, and cycling gives your body time to adapt and reset. Also worth considering: - BPC is often used more frequently and for shorter terms - TB-500 tends to be used in longer but less frequent cycles - Training load, sleep, and nutrition still do a lot of the heavy lifting If someone feels like they need them year-round just to feel okay, that’s usually a sign to look at training volume, recovery, or underlying issues rather than just extending the cycle. This is how we structure things at The Peptide Daily Brief and n1Aminos. Out of curiosity — is this for a specific injury, general joint wear-and-tear, or just staying ahead of heavy training?
1-10 of 14
John Bastiat
2
12points to level up
@john-bastiat-1751
John | The Peptide Daily Brief — Powered by Stack Tracker - research peptide insights, protocol vault & exclusive deals. No hype, just research.

Online now
Joined Oct 28, 2025
Powered by